Literature DB >> 12089262

Cross-reactivity among several recombinant calicivirus virus-like particles (VLPs) with monoclonal antibodies obtained from mice immunized orally with one type of VLP.

Noritoshi Kitamoto1, Tomoyuki Tanaka, Katsurou Natori, Naokazu Takeda, Shuji Nakata, Xi Jiang, Mary K Estes.   

Abstract

Human caliciviruses (HuCVs) are classified into the Norwalk-like viruses (NLV) and Sapporo-like viruses (SLV) as genera within the family CALICIVIRIDAE: The NLV genus is further classified into genogroups I and II, based on sequence similarities. To study the antigenic determinants on the HuCV capsid protein and develop new diagnostic tools for field samples, we established and characterized monoclonal antibodies (MAbs) against baculovirus-expressed recombinant HuCV virus-like particles (VLPs). Hybrid clones producing MAbs were obtained from cultures of PAI myeloma cells fused with spleen or mesenteric lymph node cells from mice immunized orally with either a single type of recombinant Norwalk virus (rNV), Kashiwa 47 virus (rKAV), Snow Mountain agent (rSMA), or Sapporo virus (rSV) VLP or with mixtures of two types of VLPs from different genogroups. Twenty MAbs, obtained as mouse ascites, were characterized and classified into six groups according to their enzyme-linked immunosorbent assay (ELISA) and Western blotting (WB) cross-reactivity patterns to VLPs. Five groups of MAbs reacted by both WB and ELISA and were classified as follows: common cross-reactive MAbs for four genogroup I and six genogroup II VLPs (group A), genogroup I-specific MAbs (group B), genogroup II-specific MAbs (group C), and strain-specific MAbs (groups D and E). One MAb group (group F) reacted only by ELISA. The group A MAbs, which showed broad cross-reactivity with VLPs of both NLV genogroups, were obtained from mice immunized orally with a single type of VLP (either rNV or rKAV). Two MAbs, which were obtained from mice immunized with rSV, reacted with rSV but not with any NLV VLP. These are the first MAbs to be reported for any SLV. These strain-, genogroup-, and genus-reactive MAbs will be useful tools for further study of the antigenic and structural topography of the HuCV virion and for diagnostic assays for HuCVs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12089262      PMCID: PMC120573          DOI: 10.1128/JCM.40.7.2459-2465.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  42 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  The complete nucleotide sequence of a feline calicivirus.

Authors:  M J Carter; I D Milton; J Meanger; M Bennett; R M Gaskell; P C Turner
Journal:  Virology       Date:  1992-09       Impact factor: 3.616

3.  A predominant role for Norwalk-like viruses as agents of epidemic gastroenteritis in Maryland nursing homes for the elderly.

Authors:  Kim Y Green; Gaël Belliot; Jean Lin Taylor; José Valdesuso; Judy F Lew; Albert Z Kapikian; Feng-Ying C Lin
Journal:  J Infect Dis       Date:  2002-01-03       Impact factor: 5.226

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Recombinant Norwalk virus-like particles given orally to volunteers: phase I study.

Authors:  J M Ball; D Y Graham; A R Opekun; M A Gilger; R A Guerrero; M K Estes
Journal:  Gastroenterology       Date:  1999-07       Impact factor: 22.682

6.  Norwalk virus genome cloning and characterization.

Authors:  J N Xi; D Y Graham; K N Wang; M K Estes
Journal:  Science       Date:  1990-12-14       Impact factor: 47.728

7.  Characterization of monoclonal antibodies generated against Norwalk virus GII capsid protein expressed in Escherichia coli.

Authors:  T Yoda; Y Terano; Y Suzuki; K Yamazaki; I Oishi; E Utagawa; A Shimada; S Matsuura; M Nakajima; T Shibata
Journal:  Microbiol Immunol       Date:  2000       Impact factor: 1.955

8.  Complete nucleotide sequence of the chiba virus genome and functional expression of the 3C-like protease in Escherichia coli.

Authors:  Y Someya; N Takeda; T Miyamura
Journal:  Virology       Date:  2000-12-20       Impact factor: 3.616

9.  Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis.

Authors:  A Z Kapikian; R G Wyatt; R Dolin; T S Thornhill; A R Kalica; R M Chanock
Journal:  J Virol       Date:  1972-11       Impact factor: 5.103

10.  Proteins of Norwalk virus.

Authors:  H B Greenberg; J R Valdesuso; A R Kalica; R G Wyatt; V J McAuliffe; A Z Kapikian; R M Chanock
Journal:  J Virol       Date:  1981-03       Impact factor: 5.103

View more
  36 in total

1.  Evaluation and comparison of two commercial enzyme-linked immunosorbent assay kits for detection of antigenically diverse human noroviruses in stool samples.

Authors:  Jonathan A Burton-MacLeod; Erin M Kane; Rachel S Beard; Leslie A Hadley; Roger I Glass; Tamie Ando
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

2.  Evolutionary trace residues in noroviruses: importance in receptor binding, antigenicity, virion assembly, and strain diversity.

Authors:  Sugoto Chakravarty; Anne M Hutson; Mary K Estes; B V Venkataram Prasad
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 3.  Porcine enteric caliciviruses: genetic and antigenic relatedness to human caliciviruses, diagnosis and epidemiology.

Authors:  Qiu-Hong Wang; Veronica Costantini; Linda J Saif
Journal:  Vaccine       Date:  2006-12-29       Impact factor: 3.641

4.  Characterization of a broadly reactive monoclonal antibody against norovirus genogroups I and II: recognition of a novel conformational epitope.

Authors:  Tomoyuki Shiota; Michio Okame; Sayaka Takanashi; Pattara Khamrin; Makiko Takagi; Kenji Satou; Yuichi Masuoka; Fumihiro Yagyu; Yuko Shimizu; Hideki Kohno; Masashi Mizuguchi; Shoko Okitsu; Hiroshi Ushijima
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

5.  Mapping broadly reactive norovirus genogroup I and II monoclonal antibodies.

Authors:  Sue E Crawford; Nadim Ajami; Tracy Dewese Parker; Noritoshi Kitamoto; Katsuro Natori; Naokazu Takeda; Tomoyuki Tanaka; Baijun Kou; Robert L Atmar; Mary K Estes
Journal:  Clin Vaccine Immunol       Date:  2014-11-26

6.  Characterization of cross-reactive norovirus-specific monoclonal antibodies.

Authors:  Baijun Kou; Sue E Crawford; Nadim J Ajami; Rita Czakó; Frederick H Neill; Tomoyuki N Tanaka; Noritoshi Kitamoto; Timothy G Palzkill; Mary K Estes; Robert L Atmar
Journal:  Clin Vaccine Immunol       Date:  2014-11-26

Review 7.  Comprehensive review of human sapoviruses.

Authors:  Tomoichiro Oka; Qiuhong Wang; Kazuhiko Katayama; Linda J Saif
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

8.  Heterotypic humoral and cellular immune responses following Norwalk virus infection.

Authors:  Lisa C Lindesmith; Eric Donaldson; Juan Leon; Christine L Moe; Jeffrey A Frelinger; Robert E Johnston; David J Weber; Ralph S Baric
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

9.  Heat shock protein 70 enhances mucosal immunity against human norovirus when coexpressed from a vesicular stomatitis virus vector.

Authors:  Yuanmei Ma; Yue Duan; Yongwei Wei; Xueya Liang; Stefan Niewiesk; Michael Oglesbee; Jianrong Li
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

10.  Norovirus vaccine development: next steps.

Authors:  Robert L Atmar; Mary K Estes
Journal:  Expert Rev Vaccines       Date:  2012-09       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.